Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Infant Type Hemispheric Glioma: early-phase trial registry

1 of 1 indexed Infant Type Hemispheric Glioma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Infant Type Hemispheric Glioma: 1 US clinical trial tracked, 1 recruiting.

Infant Type Hemispheric Glioma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Nationwide Children's Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition infant-type-hemispheric-glioma

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Infant Type Hemispheric (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Infant Type Hemispheric Glioma

Infant Type Hemispheric Glioma lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Infant Type Hemispheric Glioma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Infant Type Hemispheric Glioma is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Infant Type Hemispheric Glioma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Lorlatinib post Radiation Drug
1 trials
Lorlatinib with chemotherapy 2 Drug
1 trials
Lorlatinib with chemotherapy1 Drug
1 trials
Lorlatinib Drug
1 trials

US sites by state

Facility locations filed on Infant Type Hemispheric Glioma trials. A trial with sites in several states counts in each.

Washington 1 trials
Texas 1 trials
Pennsylvania 1 trials
Ohio 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Infant Type Hemispheric Glioma page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infant Type Hemispheric Glioma condition card totals 1 registered trials; most-linked intervention Lorlatinib post Radiation; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.